調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024

次世代シーケンシング（NGS）の世界市場予測（～2024年）

◆タイトル：Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024
◆商品コード：BT-2697
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年8月23日
◆ページ数：229
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオテクノロジ
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥896,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、次世代シーケンシング（NGS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別（NovaSeq、NextSeq、Sequel、ナノポア）分析、消耗品・バイオインフォマティクス・サービス別（エクソーム、RNA、DeNovo）分析、技術別（イオン、SMRT）分析、用途別（診断、がん）分析、次世代シーケンシング（NGS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2% during the forecast period. Factors such as advancements in NGS platforms, declining NGS capital cost coupled with the decreasing cost of sequencing, and improving regulatory & reimbursement scenario for NGS-based diagnostic tests are expected to drive the growth of the next-generation sequencing market.
The report analyzes the global next-generation sequencing market, by product & service, technology, application, end user, and region.

On the basis of product & service, the next-generation sequencing market is segmented into pre-sequencing products & services (DNA fragmentation, end repair, A-tailing, and size selection; library preparation & target enrichment; and quality control), NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics (NGS data analysis, storage, and management). The NGS platforms segment is further classified into Illumina (Hiseq Series, Hiseq X Ten & HiSeq X Five, Miseq Series, NextSeq 500, MiniSeq, and NovaSeq), Thermo Fisher Scientific (Ion PGM, Ion Proton, and Ion S5 & S5 XL), Pacific Biosciences (PacBio RS II and Sequel system), Oxford Nanopore Technologies, and Other Next-generation Sequencing Platforms. The NGS consumables segment is expected to account for the largest share of the next-generation sequencing market in 2018. Advancements in sequencing technologies, growing number of sequencing procedures, and launch of easy-to-use consumables are the key factors driving the growth of the consumables segment.

Based on end user, the next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these, the academic institutes & research centers segment is expected to account for the largest share of the next-generation sequencing market in 2018, owing to the increasing number of collaborations between NGS market players and academic & research institutions, favorable funding scenario for genomic research across regions, and the development of cost-efficient NGS products and services for researchers.

This report covers the next-generation sequencing market in North America (US and Canada), Europe (Germany, France, the UK, Spain, Italy, the Netherlands, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), and the Rest of the World (RoW). North America is expected to account for the largest share of the global next-generation sequencing market in 2018, followed by Europe. The large share of North America is mainly attributed to the increasing application of NGS in diagnostics and genomics research, availability of research funding, and development of NGS data analysis solutions.

As of 2017, Illumina (US) dominated the global next-generation sequencing market through its broad product portfolio, strong geographical presence, and wide customer base across the globe. To maintain its leadership position in the market, the company has been focusing on technological advancements in the field of sequencing. Thermo Fisher Scientific (US) held the second position in the global next-generation sequencing market. Other prominent players in this market include Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

【レポートの目次】

Table of Contents

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 22)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 35)
4.1 Next-Generation Sequencing (NGS): Market Overview
4.2 NGS Market, By Product & Service, 2018 vs 2024
4.3 NGS Market, By Technology, 2018 vs 2024 (USD Million)
4.4 NGS Market, By Application, 2018 vs 2024 (USD Million)
4.5 NGS Market, By End User and Region, 2018

5 Market Overview (Page No. – 38)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advancements in NGS Platforms
5.2.1.1.1 ISEQ
5.2.1.1.2 Ion Genestudio S5
5.2.1.2 Declining Costs
5.2.1.3 Improving Regulatory & Reimbursement Scenario for NGS-Based Diagnostic Tests
5.2.2 Restraints
5.2.2.1 End-User Budget Constraints in Developing Nations
5.2.3 Opportunities
5.2.3.1 Initiatives From Government & Private Bodies for Large-Scale Sequencing Projects
5.2.3.2 Application of NGS in Precision Medicine & Molecular Diagnostics
5.2.3.3 NGS Data Analysis Using Big Data
5.2.4 Challenges
5.2.4.1 Interpretation of Complex Data From NGS Platforms
5.2.4.2 Ethical Issues
5.2.5 Industry Trends
5.2.5.1 Reduction in Platform Footprint and the Development of Portable Sequencing Technology
5.2.5.2 Partnerships and Collaborations for Technological Advancements in NGS
5.2.5.3 Conferences and Workshops Increasing Awareness on NGS Products and Services

6 Next-Generation Sequencing Market, By Product & Service (Page No. – 47)
6.1 Introduction
6.2 Pre-Sequencing Products & Services
6.2.1 Sample Preparation
6.2.1.1 Dna Fragmentation, End Repair, A-Tailing, and Size Selection
6.2.1.2 Library Preparation & Target Enrichment
6.2.1.3 Quality Control
6.3 NGS Consumables, Platforms, & Services for Platforms
6.3.1 NGS Consumables
6.3.2 NGS Platforms
6.3.2.1 Illumina
6.3.2.1.1 Hiseq Series
6.3.2.1.2 Hiseq X Ten & Hiseq X Five
6.3.2.1.3 Miseq Series
6.3.2.1.4 Nextseq 500
6.3.2.1.5 Miniseq
6.3.2.1.6 Novaseq
6.3.2.2 Thermo Fisher Scientific
6.3.2.2.1 Ion PGM
6.3.2.2.2 Ion Proton
6.3.2.2.3 Ion S5 & S5 XL
6.3.2.3 Pacific Biosciences
6.3.2.3.1 Pacbio RS II
6.3.2.3.2 Sequel System
6.3.2.4 Oxford Nanopore Technologies
6.3.2.5 Other Next-Generation Sequencing Platforms
6.3.3 Services for NGS Platforms
6.4 Sequencing Services
6.4.1 Exome & Targeted Re-Sequencing and Custom Panels
6.4.2 RNA-Seq
6.4.3 Whole-Genome Sequencing & De Novo Sequencing
6.4.4 Other Sequencing Services
6.5 NGS Data Analysis, Storage, and Management (Bioinformatics)
6.5.1 NGS Data Analysis Software & Workbenches
6.5.2 NGS Data Analysis Services
6.5.3 NGS Storage, Management, and Cloud Computing Solutions

7 Next-Generation Sequencing Market, By Technology (Page No. – 78)
7.1 Introduction
7.2 Sequencing By Synthesis
7.3 Ion Semiconductor Sequencing
7.4 Single-Molecule Real-Time Sequencing
7.5 Nanopore Sequencing
7.6 Other Sequencing Technologies

8 Next-Generation Sequencing Market, By Application (Page No. – 86)
8.1 Introduction
8.2 Diagnostics
8.2.1 Cancer Diagnostics
8.2.2 Infectious Disease Diagnostics
8.2.3 Reproductive Health Diagnostics
8.2.4 Other Diagnostic Applications
8.3 Drug Discovery
8.4 Agricultural & Animal Research
8.5 Other Applications

9 Next-Generation Sequencing Market, By End User (Page No. – 98)
9.1 Introduction
9.2 Academic Institutes & Research Centers
9.3 Hospitals & Clinics
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users

10 Next-Generation Sequencing Market, By Region (Page No. – 105)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 RoE
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World

11 Competitive Landscape (Page No. – 146)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Product Launches, Product Enhancements, and Service Launches
11.3.2 Agreements, Partnerships, Collaborations, and Contracts
11.3.3 Mergers and Acquisitions
11.3.4 Expansions

12 Company Profile (Page No. – 153)
12.1 10x Genomics
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Recent Developments (2015-2018)
12.1.4 MnM View
12.2 Agilent Technologies, Inc.
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Recent Developments (2015-2018)
12.2.4 MnM View
12.3 Beckman Coulter (A Subsidiary of Danaher)
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Recent Developments (2015-2018)
12.3.4 MnM View
12.4 Becton, Dickinson and Company
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Recent Developments (2015-2018)
12.4.4 MnM View
12.5 BGI
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Services Offered
12.5.4 MnM View
12.6 Eurofins Scientific
12.6.1 Business Overview
12.6.2 Services Offered
12.6.3 Recent Developments (2015-2018)
12.6.4 MnM View
12.7 F. Hoffmann-La Roche AG
12.7.1 Business Overview
12.7.2 Products Offered
12.7.3 Recent Developments (2015-2018)
12.7.4 MnM View
12.8 Genewiz
12.8.1 Business Overview
12.8.2 Services Offered
12.8.3 Recent Developments (2015-2018)
12.8.4 MnM View
12.9 Illumina, Inc.
12.9.1 Business Overview
12.9.2 Products Offered
12.9.3 Services Offered
12.9.4 Recent Developments (2015-2018)
12.9.5 MnM View
12.10 Macrogen, Inc.
12.10.1 Business Overview
12.10.2 Services Offered
12.10.3 Recent Developments (2015-2018)
12.10.4 MnM View
12.11 Oxford Nanopore Technologies, Ltd.
12.11.1 Business Overview
12.11.2 Products Offered
12.11.3 Recent Developments (2015-2018)
12.11.4 MnM View
12.12 Pacific Biosciences of California, Inc.
12.12.1 Business Overview
12.12.2 Products Offered
12.12.3 Services Offered
12.12.4 Recent Developments (2015-2018)
12.12.5 MnM View
12.13 Perkinelmer, Inc.
12.13.1 Business Overview
12.13.2 Products & Services Offered
12.13.3 Recent Developments (2015-2018)
12.13.4 MnM View
12.14 Thermo Fisher Scientific Inc.
12.14.1 Business Overview
12.14.2 Products and Services Offered
12.14.3 Recent Developments (2015-2018)
12.14.4 MnM View
12.15 Qiagen N.V.
12.15.1 Business Overview
12.15.2 Products & Services Offered
12.15.3 Recent Developments (2015-2018)
12.15.4 MnM View

13 Appendix (Page No. – 219)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables (109 Tables)

Table 1 NGS Market, By Product & Service, 2016–2024 (USD Million)
Table 2 Pre-Sequencing Products & Services Market, By Region, 2016–2024 (USD Million)
Table 3 NGS Sample Preparation Market, By Type, 2016–2024 (USD Million)
Table 4 Dna Fragmentation, End Repair, A-Tailing, & Size Selection Market, By Region, 2016–2024 (USD Million)
Table 5 Library Preparation & Target Enrichment Market, By Region, 2016–2024 (USD Million)
Table 6 Quality Control Market, By Region, 2016–2024 (USD Million)
Table 7 NGS Platforms, Consumables, and Services for Platforms Market, By Type, 2016–2024 (USD Million)
Table 8 NGS Consumables Market, By Region, 2016–2024 (USD Million)
Table 9 NGS Platforms Market, By Type, 2016–2024 (USD Million)
Table 10 NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 11 Illumina NGS Platforms Market, By Product, 2016–2024 (USD Million)
Table 12 Illumina NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 13 Hiseq Series Platforms Market, By Region, 2016–2024 (USD Million)
Table 14 Hiseq X Ten & Hiseq X Five Platforms Market, By Region, 2016–2024 (USD Million)
Table 15 Miseq Series Platforms Market, By Region, 2016–2024 (USD Million)
Table 16 Nextseq 500 Platforms Market, By Region, 2016–2024 (USD Million)
Table 17 Miniseq Platforms Market, By Region, 2016–2024 (USD Million)
Table 18 Novaseq Platforms Market, By Region, 2016–2024 (USD Million)
Table 19 Thermo Fisher Scientific NGS Platforms Market, By Product, 2016–2024 (USD Million)
Table 20 Thermo Fisher Scientific NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 21 Ion PGM Platforms Market, By Region, 2016–2024 (USD Million)
Table 22 Ion Proton Platforms Market, By Region, 2016–2024 (USD Million)
Table 23 Ion S5 & S5 XL Platforms Market, By Region, 2016–2024 (USD Million)
Table 24 Pacific Biosciences NGS Platforms Market, By Product, 2016–2024 (USD Million)
Table 25 Pacific Biosciences NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 26 Pacbio RS II Platforms Market, By Region, 2016–2024 (USD Million)
Table 27 Sequel System Market, By Region, 2016–2024 (USD Million)
Table 28 Oxford Nanopore Technologies NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 29 Other NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 30 Services for NGS Platforms Market, By Region, 2016–2024 (USD Million)
Table 31 Sequencing Services Market, By Type, 2016–2024 (USD Million)
Table 32 Sequencing Services Market, By Region, 2016–2024 (USD Million)
Table 33 NGS Bioinformatics Market, By Product & Service, 2016–2024 (USD Million)
Table 34 NGS Bioinformatics Market, By Region, 2016–2024 (USD Million)
Table 35 Next-Generation Sequencing Technologies, By Company
Table 36 Next-Generation Sequencing Market, By Technology, 2016–2024 (USD Million)
Table 37 Sequencing By Synthesis Market, By Region, 2016–2024 (USD Million)
Table 38 Ion Semiconductor Sequencing Market, By Region, 2016–2024 (USD Million)
Table 39 Single-Molecule Real-Time Sequencing Market, By Region, 2016–2024 (USD Million)
Table 40 Nanopore Sequencing Market, By Region, 2016–2024 (USD Million)
Table 41 Other Sequencing Technologies, By Region, 2016–2024 (USD Million)
Table 42 Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 43 Next-Generation Sequencing Market for Diagnostics, By Type, 2016–2024 (USD Million)
Table 44 Next-Generation Sequencing Market for Diagnostics, By Region, 2016–2024 (USD Million)
Table 45 Next-Generation Sequencing Market for Drug Discovery, By Region, 2016–2024 (USD Million)
Table 46 Next-Generation Sequencing Market for Agricultural and Animal Research, By Region, 2016–2024 (USD Million)
Table 47 Next-Generation Sequencing Market for Other Applications, By Region, 2016–2024 (USD Million)
Table 48 Next-Generation Sequencing Market, By End User, 2016–2024 (USD Million)
Table 49 Next-Generation Sequencing Market for Academic Institutes & Research Centers, By Region, 2016–2024 (USD Million)
Table 50 Next-Generation Sequencing Market for Hospitals & Clinics, By Region, 2016–2024 (USD Million)
Table 51 Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2016–2024 (USD Million)
Table 52 Next-Generation Sequencing Market for Other End Users, By Region, 2016–2024 (USD Million)
Table 53 Next-Generation Sequencing Market, By Region, 2016–2024 (USD Million)
Table 54 North America: Next-Generation Sequencing Market, By Country, 2016–2024 (USD Million)
Table 55 North America: Next-Generation Sequencing Market, By Product & Service, 2016–2024 (USD Million)
Table 56 North America: Pre-Sequencing Products & Services Market, By Type, 2016–2024 (USD Million)
Table 57 North America: Next-Generation Sequencing Platforms Market, By Type, 2016–2024 (USD Million)
Table 58 North America: Illumina Platforms Market, By Type, 2016–2024 (USD Million)
Table 59 North America: Thermo Fisher Scientific Platforms Market, By Type, 2016–2024 (USD Million)
Table 60 North America: Pacific Biosciences Platforms Market, By Type, 2016–2024 (USD Million)
Table 61 North America: Next-Generation Sequencing Market, By Technology, 2016–2024 (USD Million)
Table 62 North America: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 63 North America: Next-Generation Sequencing Market, By End User, 2016–2024 (USD Million)
Table 64 US: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 65 Canada: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 66 Europe: Next-Generation Sequencing Market, By Country, 2016–2024 (USD Million)
Table 67 Europe: Next-Generation Sequencing Market, By Product & Service, 2016–2024 (USD Million)
Table 68 Europe: Pre-Sequencing Products & Services Market, By Type, 2016–2024 (USD Million)
Table 69 Europe: Next-Generation Sequencing Platforms Market, By Type, 2016–2024 (USD Million)
Table 70 Europe: Illumina Platforms Market, By Type, 2016–2024 (USD Million)
Table 71 Europe: Thermo Fisher Scientific Platforms Market, By Type, 2016–2024 (USD Million)
Table 72 Europe: Pacific Biosciences Platforms Market, By Type, 2016–2024 (USD Million)
Table 73 Europe: Next-Generation Sequencing Market, By Technology, 2016–2024 (USD Million)
Table 74 Europe: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 75 Europe: Next-Generation Sequencing Market, By End User, 2016–2024 (USD Million)
Table 76 Germany: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 77 UK: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 78 France: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 79 Spain: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 80 Italy: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 81 Netherlands: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 82 RoE: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 83 Asia Pacific: Next-Generation Sequencing Market, By Country, 2016–2024 (USD Million)
Table 84 Asia Pacific: Next-Generation Sequencing Market, By Product & Service, 2016–2024 (USD Million)
Table 85 Asia Pacific: Pre-Sequencing Products & Services Market, By Type, 2016–2024 (USD Million)
Table 86 Asia Pacific: Next-Generation Sequencing Platforms Market, By Type, 2016–2024 (USD Million)
Table 87 Asia Pacific: Illumina Platforms Market, By Type, 2016–2024 (USD Million)
Table 88 Asia Pacific: Thermo Fisher Scientific Platforms Market, By Type, 2016–2024 (USD Million)
Table 89 Asia Pacific: Pacific Biosciences Platforms Market, By Type, 2016–2024 (USD Million)
Table 90 Asia Pacific: Next-Generation Sequencing Market, By Technology, 2016–2024 (USD Million)
Table 91 Asia Pacific: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 92 Asia Pacific: Next-Generation Sequencing Market, By End User, 2016–2024 (USD Million)
Table 93 China: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 94 Japan: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 95 India: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 96 RoAPAC: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 97 RoW: Next-Generation Sequencing Market, By Product & Service, 2016–2024 (USD Million)
Table 98 RoW: Pre-Sequencing Products & Services Market, By Type, 2016–2024 (USD Million)
Table 99 RoW: Next-Generation Sequencing Platforms Market, By Type, 2016–2024 (USD Million)
Table 100 RoW: Illumina Platforms Market, By Type, 2016–2024 (USD Million)
Table 101 RoW: Thermo Fisher Scientific Platforms Market, By Type, 2016–2024 (USD Million)
Table 102 RoW: Pacific Biosciences Platforms Market, By Type, 2016–2024 (USD Million)
Table 103 RoW: Next-Generation Sequencing Market, By Technology, 2016–2024 (USD Million)
Table 104 RoW: Next-Generation Sequencing Market, By Application, 2016–2024 (USD Million)
Table 105 RoW: Next-Generation Sequencing Market, By End User, 2016–2024 (USD Million)
Table 106 Key Launches, Product Enhancements, and Service Launches 2017–2018 (July)
Table 107 Key Five Agreements, Partnerships, Collaborations, and Contracts, 2017–2018 (July)
Table 108 Key Mergers and Acquisitions, 2017–2018 (July)
Table 109 Key Geographic Expansions, 2017–2018 (July)

List of Figures (44 Figures)

Figure 1 Next-Generation Sequencing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 NGS Market: Bottom-Up Approach
Figure 5 NGS Platforms Market: Bottom-Up Approach
Figure 6 NGS Market: Top-Down Approach
Figure 7 NGS Market: Data Triangulation
Figure 8 Next-Generation Sequencing Market, By Application, 2018 vs 2024 (USD Million)
Figure 9 Next-Generation Sequencing Market, By Product & Service, 2018 vs 2024 (USD Million)
Figure 10 Next-Generation Sequencing Market, By Technology, 2018 vs 2024 (USD Million)
Figure 11 Next-Generation Sequencing Market, By End User, 2018 vs 2024 (USD Million)
Figure 12 Geographic Snapshot: Next-Generation Sequencing Market
Figure 13 NGS Market is Expected to Register A Double-Digit Growth Rate
Figure 14 Consumables Segment is Expected to Account for the Major Share During Forecast Period
Figure 15 Sequencing By Synthesis Segment to Dominate the Market in 2024
Figure 16 Diagnostics Segment is Expected to Grow at the Highest Rate During the Study Period
Figure 17 Academic Institutes and Research Centers Segment to Account for the Largest Share of the Market
Figure 18 NGS Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Cost of Human Whole-Genome Sequencing, 2001–2017
Figure 20 Comparison of System/Platform Costs, By Company
Figure 21 Consumables Segment to Dominate the Next-Generation Sequencing Market in 2018
Figure 22 Nanopore Sequencing is Expected to Register the Highest CAGR During the Forecast Period (2018 to 2024)
Figure 23 Diagnostics Segment Will Continue to Dominate the Next-Generation Sequencing Applications Market Till 2024
Figure 24 Cancer Diagnostics to Dominate the Next-Generation Sequencing Diagnostic Applications Market Till 2024
Figure 25 Funding for Cancer Research From the National Cancer Institute (2016)
Figure 26 Number of Pubmed Research Publications on NGS-Based Drug Discovery, 2008–2017
Figure 27 Hospitals & Clinics Segment is Expected to Grow at the Highest Rate During the Study Period
Figure 28 North America: Next-Generation Sequencing Market Snapshot
Figure 29 Europe: Next-Generation Sequencing Market Snapshot
Figure 30 Asia Pacific: Next-Generation Sequencing Market Snapshot
Figure 31 RoW: Next-Generation Sequencing Market Snapshot
Figure 32 Key Developments in the Next-Generation Sequencing Market, Jan 2015 to July 2018
Figure 33 Next-Generation Sequencing Market Share Analysis, By Key Player, 2017
Figure 34 Next-Generation Sequencing Platform Market Share Analysis, By Key Player, 2017
Figure 35 Agilent Technologies: Company Snapshot (2017)
Figure 36 Danaher Corporation: Company Snapshot (2017)
Figure 37 Becton, Dickinson and Company: Company Snapshot (2017)
Figure 38 Eurofins Scientific: Company Snapshot (2017)
Figure 39 Roche: Company Snapshot (2017)
Figure 40 Illumina: Company Snapshot (2017)
Figure 41 Pacific Biosciences of California: Company Snapshot (2017)
Figure 42 Perkinelmer, Inc.: Company Snapshot (2017)
Figure 43 Thermo Fisher Scientific: Company Snapshot (2017)
Figure 44 Qiagen N.V.: Company Snapshot (2017)

★調査レポート[次世代シーケンシング（NGS）の世界市場予測（～2024年）] ( Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024 / BT-2697) 販売に関する免責事項
[次世代シーケンシング（NGS）の世界市場予測（～2024年）] ( Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024 / BT-2697) についてEメールでお問い合わせ
◆関連調査資料◆
  • 次世代シーケンシング（NGS）の世界市場予測（～2022）
  • 次世代シーケンシング（NGS）サービスの世界市場予測（～2022年）
  • 臓器移植検査の世界市場：血清学的検査、混合リンパ球培養試験（MLC）、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）
  • TSN（Time-Sensitive Networking）の世界市場予測（～2024年）：スイッチ、ハブ、ルータ、ゲートウェイ、メモリ
  • グルコース/ブドウ糖/マルトデキストリンの世界市場予測（～2024年）
  • 癌・腫瘍プロファイリングの世界市場予測（～2021）：用途別、手法別（ゲノミクス、 プロテオミクス、メタボロミクス、エピジェネティックス）、技術別（次世代シーケンシング、qPCR、in-situハイブリダイゼーション、マイクロアレイ）
  • 血液検査の世界市場：技術（核酸増幅検査（NAT）、ELISA法、EIA法、CLIA法、次世代シーケンシング、ウエスタンブロット法）、試薬、装置
  • 飼料用リン酸塩の世界市場予測（～2024年）
  • 防空システムの世界市場予測（～2024年）
  • 次世代シークエンシング（NGS）の世界市場予測（～2021）

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆